brequinar has been researched along with aspirin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Aungst, BJ; Blake, JA; Dusak, BA; Rogers, NJ | 1 |
2 other study(ies) available for brequinar and aspirin
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Effects of plasma protein binding displacement on the pharmacokinetics, tissue and tumor concentrations and efficacy of brequinar, a highly protein-bound antitumor agent.
Topics: Animals; Antineoplastic Agents; Aspirin; Biphenyl Compounds; Blood Proteins; Dose-Response Relationship, Drug; Drug Interactions; Female; Humans; Ibuprofen; Leukemia L1210; Male; Mice; Protein Binding; Rats; Rats, Inbred Lew; Tissue Distribution | 1990 |